Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001079973-25-001052·Aptevo Therapeutics Inc.
Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock · CUSIP: 03835L504
Event date: 2025-04-26
- Filing-level shares
- 20,000.00
- Percent of class
- 0.70%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 20,000.00 · Class: 0.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-001052
- Form type
- SCHEDULE 13G/A
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Jun 23, 2025
- Reporting period
- Apr 26, 2025
- Description
- Schedule 13G beneficial ownership